Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulated factor
AssigneeAventis Pasteur Limited
InventorsBarbara Papadopoulu, Marc Ouellette, Martin Olivier
Life of this patent
Estimating the term…
Abstract
Strains of Leishmania and other macrophage-infecting parasites are provided which express the GM-CSF gene which are useful in treating hosts infected by the parasite and in protecting hosts against disease caused by infection of hosts by parasites. The parasites are reduced in their ability to infect or survive in macrophages and hence are attenuated. At least one gene of the parasite contributing to the virulence thereto may be functionally disabled. The attenuated strains may be used for administration to a host (a) to treat a host infected by Leishmania or (b) to confer protection against disease caused by a virulent Leishmania strain, or as a diagnostic reagent.
Claims8
A macrophage infecting parasite which is a strain of Leishmania and which is transformed by a plasmid containing a nucleic acid molecule encoding a granulocyte macrophage colony stimulating factor (GM-CSF) and which parasite expresses GM-CSF.
A macrophage infecting parasite which is a strain of Leishmania and which is transformed by a plasmid containing a nucleic acid molecule encoding a granulocyte macrophage colony stimulating factor (GM-CSF) e and which parasite expresses GM-CSF and at least one additional cytokine.
A macrophage infecting parasite which is a strain of Leishmania selected from the group consisting of Leishmania donovani and Leishmania major and which has been transformed by a plasmid vector selected from the group consisting of pneo-mGM CSF and pneo-hGM CSF and-which expresses a granulocyte macrophage colony stimulating factor (GM-CSF).
Dependencies are inferred from the claim text.